VaccineIllness, disability, injury or condition coveredTime period for first symptom
I. Vaccines containing tetanus toxoid (e.g., DTaP, DTP, DT, Td, or TT)A. Anaphylaxis or anaphylactic shock
B. Brachial Neuritis
C. Any acute complication or sequela (including death) of an illness, disability, injury, or condition referred to above which illness, disability, injury, or condition arose within the time period prescribed
A. 4 hours.

B. 2-28 days.
II. Vaccines containing whole cell pertussis bacteria, extracted or partial cell pertussis bacteria, or specific pertussis antigen(s) (e.g., DTP, DTaP, P, DTP-Hib)A. Anaphylaxis or anaphylactic shock
   
B. Encephalopathy (or encephalitis)
   
C. Any acute complication or sequela (including death) of an illness, disability, injury, or condition referred to above which illness, disability, injury, or condition arose within the time period prescribed
A. 4 hours


B. 72 hours
III. Measles, mumps, and rubella vaccine or any of its components (e.g., MMR, MR, M, R)A. Anaphylaxis or anaphylactic shock
   
B. Encephalopathy (or encephalitis)
   
C. Any acute complication or sequela (including death) of an illness, disability, injury, or condition referred to above which illness, disability, injury, or condition arose within the time period prescribed
A. 4 hours.


B. 5-15 days (not less than 5 days and not more than 15 days).
IV. Vaccines containing rubella virus (e.g., MMR, MR, R)A. Chronic arthritis
   
B. Any acute complication or sequela (including death) of an illness, disability, injury, or condition referred to above which illness, disability, injury, or condition arose within the time period prescribed
A. 7-42 days.
V. Vaccines containing measles virus (e.g., MMR, MR, M)A. Thrombocytopenic purpura
   
B. Vaccine-Strain Measles Viral Infection in an immunodeficient recipient
   
C. Any acute complication or sequela (including death) of an illness, disability, injury, or condition referred to above which illness, disability, injury, or condition arose within the time period prescribed
A. 7-30 days.



B. 6 months.
VI. Vaccines containing polio live virus (OPV)A. Paralytic Polio
—in a non-immunodeficient recipient
—in an immunodeficient recipient
—in a vaccine associated community case
   
B. Vaccine-Strain Polio Viral Infection 
—in a non-immunodeficient recipient
—in an immunodeficient recipient   
—in a vaccine associated community case
   
C. Any acute complication or sequela (including death) of an illness, disability, injury, or condition referred to above which illness, disability, injury, or condition arose within the time period prescribed

30 days.

6 months.






30 days.

6 months.

   
VII. Vaccines containing polio inactivated virus (e.g., IPV)A. Anaphylaxis or anaphylactic shock

   
B. Any acute complication or sequela (including death of an illness, disability, injury, or condition referred to above which illness, disability, injury, or condition arose within the time period prescribed.
A. 4 hours
VIII. Hepatitis B. vaccinesA. Anaphylaxis or anaphylactic shock
   
B. Any acute complication or sequela (including death) of an illness, disability, injury, or condition referred to above which illness, disability, injury, or condition arose within the time period prescribed
A. 4 hours.
IX. Hemophilus influenzae type b polysaccharide conjugate vaccinesNo Condition Specified
X. Varicella vaccineNo Condition Specified
XI. Rotavirus vaccineA. Intussusception 

B. Any acute complication or sequela (including death) of an illness, disability, injury, or condition referred to above which illness, disability, injury, or condition arose within the time period prescribed.
A. 1-21 days
XII. Pneumococcal conjugate vaccinesNo Condition Specified
XIII. Hepatitis A vaccinesNo Condition Specified
XIV. Trivalent influenza vaccinesNo Condition Specified
XV. Meningococcal vaccinesNo Condition Specified
XVI. Human papillomavirus (HPV) vaccinesNo Condition Specified

XVII. Any new vaccine recommended by the Centers for Disease Control and Prevention for routine administration to children, after publication by the Secretary of a notice of coverage*

*HRSA note: Now includes all vaccines against seasonal influenza (except trivalent influenza vaccines, which are already covered), effective November 12, 2013.